Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 kinase in Parkinson's disease
Dario R. Alessi, Esther Sammler
Science (2018) Vol. 360, Iss. 6384, pp. 36-37
Open Access | Times Cited: 299

Showing 1-25 of 299 citing articles:

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 803
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen, Darren A.E. Cross, Pasi A. Jänne
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 551-569
Open Access | Times Cited: 783
To degrade or not to degrade: mechanisms and significance of endocytic recycling
Peter J. Cullen, Florian Steinberg
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 11, pp. 679-696
Closed Access | Times Cited: 493
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa, Miquel Vila, Christine Klein, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 2, pp. 97-107
Closed Access | Times Cited: 375
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state
Semra Smajić, Cesar A. Prada‐Medina, Zied Landoulsi, et al.
Brain (2021) Vol. 145, Iss. 3, pp. 964-978
Open Access | Times Cited: 330
Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
Tim Bartels, Sebastiaan De Schepper, Soyon Hong
Science (2020) Vol. 370, Iss. 6512, pp. 66-69
Open Access | Times Cited: 312
Historical Perspective: Models of Parkinson’s Disease
Shyh Jenn Chia, Eng‐King Tan, Yinxia Chao
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2464-2464
Open Access | Times Cited: 303
The different autophagy degradation pathways and neurodegeneration
Angeleen Fleming, Mathieu Bourdenx, Motoki Fujimaki, et al.
Neuron (2022) Vol. 110, Iss. 6, pp. 935-966
Open Access | Times Cited: 302
Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Michaela Johnson, Benjamin Stecher, Viviane Labrie, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 1, pp. 4-13
Open Access | Times Cited: 273
A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
Herschel S. Dhekne, Izumi Yanatori, Rachel C. Gomez, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 226
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Katja Badanjak, Sonja Fixemer, Semra Smajić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4676-4676
Open Access | Times Cited: 194
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
The genetic landscape of Parkinson's disease
Ariane Lunati, Suzanne Lesage, Alexis Brice
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 628-643
Open Access | Times Cited: 189
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, Luc Bousset, et al.
Acta Neuropathologica (2019) Vol. 137, Iss. 6, pp. 961-980
Open Access | Times Cited: 166
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vázquez-Vélez, Huda Y. Zoghbi
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 87-108
Open Access | Times Cited: 156
Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan Holbrook, Heledd Jarosz-Griffiths, Emily A. Caseley, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 149
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration
Fangjie Shao, Xiaoyu Wang, Haijian Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 142
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
Sebastian Virreira Winter, Özge Karayel, Maximilian T. Strauss, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 3
Open Access | Times Cited: 120
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
Özge Karayel, Sebastian Virreira Winter, Shalini Padmanabhan, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100661-100661
Open Access | Times Cited: 113
Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood–Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2
Xingui Liu, Alexia F. Kalogeropulou, Sofia Domingos, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 37, pp. 16930-16952
Open Access | Times Cited: 110
Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
Alexia F. Kalogeropulou, Elena Purlyte, Francesca Tonelli, et al.
Biochemical Journal (2022) Vol. 479, Iss. 17, pp. 1759-1783
Open Access | Times Cited: 90
A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
Rui Qi, Esther Sammler, Claudia P. González-Hunt, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Open Access | Times Cited: 43
Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 21
Mitochondrial Dysfunction in Neurodegenerative Diseases
Han‐Mo Yang
Cells (2025) Vol. 14, Iss. 4, pp. 276-276
Open Access | Times Cited: 2
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease
Cleusa Adriane Menegassi Bianchi Krüger, Shen‐Yang Lim, Alissa Buhrmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top